| [1] |
Liver Disease Committee, Chinese Association of Integrative Medicine. Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice (2019)[J]. J Clin Hepatol, 2019, 35(7): 1444-1449. DOI: 10.3969/j.issn.1001-5256.2019.07.007.
中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(7): 1444-1449. DOI: 10.3969/j.issn.1001-5256.2019.07.007.
|
| [2] |
SARKAR M, DODGE JL, GREENBLATT RM, et al. Reproductive aging and hepatic fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected women[J]. Clin Infect Dis, 2017, 65(10): 1695-1702. DOI: 10.1093/cid/cix643. |
| [3] |
YANG JD, ABDELMALEK MF, PANG H, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis[J]. Hepatology, 2014, 59(4): 1406-1414. DOI: 10.1002/hep.26761. |
| [4] |
KLAIR JS, YANG JD, ABDELMALEK MF, et al. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease[J]. Hepatology, 2016, 64(1): 85-91. DOI: 10.1002/hep.28514. |
| [5] |
JIA M, DAHLMAN-WRIGHT K, GUSTAFSSON JÅ. Estrogen receptor alpha and beta in health and disease[J]. Best Pract Res Clin Endocrinol Metab, 2015, 29(4): 557-568. DOI: 10.1016/j.beem.2015.04.008. |
| [6] |
BONDER A, TAPPER EB, AFDHAL NH. Contemporary assessment of hepatic fibrosis[J]. Clin Liver Dis, 2015, 19(1): 123-134. DOI: 10.1016/j.cld.2014.09.007. |
| [7] |
PARK SH, PARK YE, LEE J, et al. Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women[J]. Climacteric, 2020, 23(2): 173-177. DOI: 10.1080/13697137.2019.1650018. |
| [8] |
ROBSON SC, NEUBERGER JM, WILLIAMS R. The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis[J]. J Hepatol, 1994, 21(3): 412-416. DOI: 10.1016/s0168-8278(05)80321-6. |
| [9] |
RINALDI M, CAGNACCI A, PANSINI FE, et al. Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis[J]. Menopause, 2005, 12(5): 619-622. DOI: 10.1097/01.gme.0000172271.78314.6d. |
| [10] |
PADUA MA, FONSECA AM, DEGUTI MM, et al. Hormone therapy in Brazilian postmenopausal women with chronic hepatitis C: A pilot study[J]. Climacteric, 2010, 13(2): 179-186. DOI: 10.3109/13697130902952577. |
| [11] |
EZHILARASAN D, SOKAL E, NAJIMI M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(3): 192-197. DOI: 10.1016/j.hbpd.2018.04.003. |
| [12] |
XU MC, ZHANG F, ZHUGE YZ. Current research status of mechanisms of the development and progression of liver fibrosis[J]. J Clin Hepatol, 2016, 32(9): 1806-1809. DOI: 10.3969/j.issn.1001-5256.2016.09.039.
徐明翠, 张峰, 诸葛宇征. 肝纤维化发生发展机制的研究现状[J]. 临床肝胆病杂志, 2016, 32(9): 1806-1809. DOI: 10.3969/j.issn.1001-5256.2016.09.039.
|
| [13] |
BLANER WS, LI Y, BRUN PJ, et al. Vitamin A absorption, storage and mobilization[J]. Subcell Biochem, 2016, 81: 95-125. DOI: 10.1007/978-94-024-0945-1_4. |
| [14] |
SENOO H, MEZAKI Y, FUJIWARA M. The stellate cell system (vitamin A-storing cell system)[J]. Anat Sci Int, 2017, 92(4): 387-455. DOI: 10.1007/s12565-017-0395-9. |
| [15] |
CAI X, LI Z, ZHANG Q, et al. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis[J]. J Cell Mol Med, 2018, 22(10): 5050-5061. DOI: 10.1111/jcmm.13787. |
| [16] |
SUTTI S, TACKE F. Liver inflammation and regeneration in drug-induced liver injury: Sex matters![J]. Clin Sci (Lond), 2018, 132(5): 609-613. DOI: 10.1042/CS20171313. |
| [17] |
QUE R, SHEN Y, REN J, et al. Estrogen receptor-β-dependent effects of saikosaponin-d on the suppression of oxidative stress-induced rat hepatic stellate cell activation[J]. Int J Mol Med, 2018, 41(3): 1357-1364. DOI: 10.3892/ijmm.2017.3349. |
| [18] |
GE S, XIE J, LIU F, et al. MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol[J]. J Cell Biochem, 2015, 116(11): 2455-2464. DOI: 10.1002/jcb.25116. |
| [19] |
PAROLA M, PINZANI M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65: 37-55. DOI: 10.1016/j.mam.2018.09.002. |
| [20] |
ZHANG M, WANG Y, ZHU G, et al. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice[J]. Naunyn Schmiedebergs Arch Pharmacol, 2021, 394(1): 189-204. DOI: 10.1007/s00210-020-01891-5. |
| [21] |
EZHILARASAN D. Critical role of estrogen in the progression of chronic liver diseases[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(5): 429-434. DOI: 10.1016/j.hbpd.2020.03.011. |
| [22] |
DENG YY, GE SF, YU YQ, et al. Cell signaling pathways associated with liver fibrosis and potential therapeutic strategie[J]. J Clin Hepatol, 2020, 36(5): 114. DOI: 10.3969/j.issn.1001-5256.2020.05.043.
邓羊羊, 葛善飞, 余燕青, 等. 肝纤维化相关细胞信号转导通路及潜在治疗策略[J]. 临床肝胆病杂志, 2020, 36(5): 114. DOI: 10.3969/j.issn.1001-5256.2020.05.043.
|
| [23] |
HAN R, HU M, ZHONG Q, et al. Perfluorooctane sulphonate induces oxidative hepatic damage via mitochondria-dependent and NF-κB/TNF-α-mediated pathway[J]. Chemosphere, 2018, 191: 1056-1064. DOI: 10.1016/j.chemosphere.2017.08.070. |
| [24] |
KAZANKOV K, JØRGENSEN S, THOMSEN KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(3): 145-159. DOI: 10.1038/s41575-018-0082-x. |
| [25] |
OISHI Y, MANABE I. Macrophages in inflammation, repair and regeneration[J]. Int Immunol, 2018, 30(11): 511-528. DOI: 10.1093/intimm/dxy054. |
| [26] |
YU Y, LIU Y, AN W, et al. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis[J]. J Clin Invest, 2019, 129(2): 546-555. DOI: 10.1172/JCI121842. |
| [27] |
SU L, LI N, TANG H, et al. Kupffer cell-derived TNF-α promotes hepatocytes to produce CXCL1 and mobilize neutrophils in response to necrotic cells[J]. Cell Death Dis, 2018, 9(3): 323. DOI: 10.1038/s41419-018-0377-4. |
| [28] |
TONELLI C, CHIO I, TUVESON DA. Transcriptional regulation by Nrf2[J]. Antioxid Redox Signal, 2018, 29(17): 1727-1745. DOI: 10.1089/ars.2017.7342. |
| [29] |
BONNARDEL J, T'JONCK W, GAUBLOMME D, et al. Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche[J]. Immunity, 2019, 51(4): 638-654. e9. DOI: 10.1016/j.immuni.2019.08.017. |
| [30] |
ANNESLEY SJ, FISHER PR. Mitochondria in health and disease[J]. Cells, 2019, 8(7). DOI: 10.3390/cells8070680. |
| [31] |
ZHANG L, WANG X, CUETO R, et al. Biochemical basis and metabolic interplay of redox regulation[J]. Redox Biol, 2019, 26: 101284. DOI: 10.1016/j.redox.2019.101284. |
| [32] |
ZHAO Y, WANG Z, FENG D, et al. p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species[J]. Theranostics, 2019, 9(5): 1510-1522. DOI: 10.7150/thno.29620. |
| [33] |
JIA M, DAHLMAN-WRIGHT K, GUSTAFSSON JÅ. Estrogen receptor alpha and beta in health and disease[J]. Best Pract Res Clin Endocrinol Metab, 2015, 29(4): 557-568. DOI: 10.1016/j.beem.2015.04.008. |
| [34] |
KLINGE CM. Estrogens regulate life and death in mitochondria[J]. J Bioenerg Biomembr, 2017, 49(4): 307-324. DOI: 10.1007/s10863-017-9704-1. |
| [35] |
BESSE-PATIN A, LÉVEILLÉ M, OROPEZA D, et al. Estrogen signals through peroxisome proliferator-activated receptor-γ coactivator 1α to reduce oxidative damage associated with diet-induced fatty liver disease[J]. Gastroenterology, 2017, 152(1): 243-256. DOI: 10.1053/j.gastro.2016.09.017. |
| [36] |
|
| [37] |
VILLALBA M, ALEXIA C, BELLIN-ROBERT A, et al. Non-genetically improving the natural cytotoxicity of Natural Killer (NK) cells[J]. Front Immunol, 2019, 10: 3026. DOI: 10.3389/fimmu.2019.03026. |
| [38] |
LI T, YANG Y, SONG H, et al. Activated NK cells kill hepatic stellate cells via p38/PI3K signaling in a TRAIL-involved degranulation manner[J]. J Leukoc Biol, 2019, 105(4): 695-704. DOI: 10.1002/JLB.2A0118-031RR. |
| [39] |
MACEK JILKOVA Z, DECAENS T, MARLU A, et al. Sex differences in spontaneous degranulation activity of intrahepatic natural killer cells during chronic hepatitis B: Association with estradiol levels[J]. Mediators Inflamm, 2017, 2017: 3214917. DOI: 10.1155/2017/3214917. |
| [40] |
JIAO J, OOKA K, FEY H, et al. Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice[J]. J Hepatol, 2016, 65(2): 344-353. DOI: 10.1016/j.jhep.2016.04.020. |
| [41] |
SHEN H, SHENG L, XIONG Y, et al. Thymic NF-κB-inducing kinase regulates CD4(+) T cell-elicited liver injury and fibrosis in mice[J]. J Hepatol, 2017, 67(1): 100-109. DOI: 10.1016/j.jhep.2017.02.025. |
| [42] |
CHENG LS, LIU Y, JIANG W. Restoring homeostasis of CD4 + T cells in hepatitis-B-virus-related liver fibrosis[J]. World J Gastroenterol, 2015, 21(38): 10721-10731. DOI: 10.3748/wjg.v21.i38.10721. |
| [43] |
MILETTE S, HASHIMOTO M, PERRINO S, et al. Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases[J]. Nat Commun, 2019, 10(1): 5745. DOI: 10.1038/s41467-019-13571-x. |
| [44] |
STUBELIUS A, ERLANDSSON MC, ISLANDER U, et al. Immunomodulation by the estrogen metabolite 2-methoxyestradiol[J]. Clin Immunol, 2014, 153(1): 40-48. DOI: 10.1016/j.clim.2014.03.011. |
| [45] |
CHESTER RC, KLING JM, MANSON JE. What the women's health initiative has taught us about menopausal hormone therapy[J]. Clin Cardiol, 2018, 41(2): 247-252. DOI: 10.1002/clc.22891. |
DownLoad: